50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
- RxCUI
- 1091167
- RxNorm name
- 50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
- Display name
- 50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
- Full name
- 50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| effd952d-ac94-47bb-b107-589a4934dcca | Ritalin LA 20 MG 24HR Extended Release Oral Capsule [PSN] · 50/50 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule [Ritalin] [SBD] · Ritalin LA 20 MG 24 HR Extended Release Oral Capsule [SY] | 3 | 36 | These highlights do not include all the information needed to use RITALIN LA safely and effectively. See full prescribing information for RITALIN LA. RITALIN LA ® (methylphenidate hydrochloride) extended-release capsules for oral use, CII Initial U.S. Approval: 1955 | 20250923 |